CDC Recommends Pfizer/BioNTech COVID-19 Booster Shots For Kids Aged 5-11 Years

  • The Centers for Disease Control and Prevention recommended that children ages 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc PFE and BioNTech SE BNTX.
  • Following the recommendation, many of the nation's doctors, pharmacies, and other vaccination sites are expected to begin offering the extra doses to the 28 million U.S. children in the age group.
  • The shots are to be given five months after the second dose. The extra dose is one-third of those 12 years old and above receive.
  • Related: FDA Gives Green Signal To Pfizer/BioNTech's COVID-19 Booster For Kids 5-11 Years.
  • Also, the CDC said it was strengthening its recommendation that people 12 years and older who are immunocompromised or who are 50 and older should receive a second booster dose at least four months after their first.
  • "We know that these vaccines are safe, and we must continue to increase the number of children who are protected," CDC director Rochelle Walensky said.
  • Since the pandemic, over 4.8 million children 5 to 11 years have been diagnosed with COVID-19, 15,000 have been hospitalized, and over 180 have died.
  • Price Action: PFE shares traded 0.39% higher at $50.85, and BNTX stock is up 0.61% at $168.90 during the premarket session on the last check Friday.
  • Photo by x3 from Pixabay
Loading...
Loading...
BNTX Logo
BNTXBioNTech SE
$105.02-0.42%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
Not Available
Growth
Not Available
Quality
Not Available
Value
55.97
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...